RNA drugs might be able to protect against a huge range of viruses by turning on key parts of our innate defences against infection ...

Researchers at Arizona State University have developed a breakthrough diagnostic tool that could transform how quickly and ...

Discover OraSure Technologies' Q2 2025 highlights: strong product launches, expanded leadership, and operational milestones amid market challenges.

The investigational tuberculosis vaccine M72/AS01E-4 has an acceptable safety profile and robust immunogenicity among ...

In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...

Once-weekly semaglutide significantly slowed epigenetic aging in adults with HIV-associated lipohypertrophy, as measured by ...

Starting in the mid-2010s, the University of Oxford pediatrician and immunologist began working with scientists in the South African province of KwaZulu-Natal, with the aim of tracking several hundred ...

Evidence is growing that some HIV-infected infants, if given antiretroviral drugs early in life, are able to suppress their ...

HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...

A research team from Kumamoto University has made a groundbreaking discovery that reveals how the human T-cell leukemia virus ...

Generating effective protection against HIV may require a complex vaccine consisting of a series of different viral proteins. Now, two trials of the potential components delivered via mRNA have ...